Stanley Laman Group Ltd. decreased its holdings in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 19.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 159,469 shares of the company's stock after selling 38,199 shares during the period. Stanley Laman Group Ltd. owned about 0.22% of Schrödinger worth $3,076,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. KBC Group NV increased its stake in shares of Schrödinger by 45.4% during the third quarter. KBC Group NV now owns 2,508 shares of the company's stock valued at $47,000 after buying an additional 783 shares during the period. Quarry LP grew its holdings in Schrödinger by 1,150.0% during the 3rd quarter. Quarry LP now owns 2,825 shares of the company's stock worth $52,000 after acquiring an additional 2,599 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Schrödinger by 87.5% during the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock worth $54,000 after buying an additional 1,305 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in Schrödinger in the third quarter valued at about $102,000. Finally, Point72 DIFC Ltd purchased a new position in Schrödinger in the third quarter valued at about $151,000. 79.05% of the stock is currently owned by institutional investors.
Schrödinger Stock Performance
Shares of NASDAQ:SDGR traded up $0.42 during trading on Monday, hitting $24.85. The company's stock had a trading volume of 1,584,013 shares, compared to its average volume of 1,004,547. Schrödinger, Inc. has a fifty-two week low of $16.67 and a fifty-two week high of $33.63. The business has a 50 day moving average price of $21.87 and a two-hundred day moving average price of $20.35. The company has a market capitalization of $1.81 billion, a PE ratio of -10.62 and a beta of 1.61.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the company. BMO Capital Markets raised their target price on Schrödinger from $25.00 to $28.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 13th. KeyCorp lifted their target price on Schrödinger from $25.00 to $27.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $32.11.
Check Out Our Latest Stock Report on SDGR
Schrödinger Company Profile
(
Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Articles
Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
